Patent: 9,089,578
Summary for Patent: 9,089,578
| Title: | Method of treating neuroendocrine tumors |
| Abstract: | Methods and compositions for treating neuroendocrine tumors are disclosed. |
| Inventor(s): | Hooshmand SHESHBARADARAN, William McCulloch |
| Assignee: | Intezyne Technologies Inc , Niiki Pharma Acquisition Corp 2 |
| Application Number: | US13/869,975 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,089,578
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases, Inc. | SYLVANT | siltuximab | For Injection | 125496 | April 23, 2014 | ⤷ Start Trial | 2033-04-25 |
| Eusa Pharma (uk) Limited | SYLVANT | siltuximab | For Injection | 125496 | April 23, 2014 | ⤷ Start Trial | 2033-04-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 9,089,578
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2011323832 | ⤷ Start Trial |
| European Patent Office | 2632459 | ⤷ Start Trial |
| Japan | 2013540816 | ⤷ Start Trial |
| Japan | 6116481 | ⤷ Start Trial |
| South Korea | 101639470 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
